Exploiting vulnerabilities in cancer signalling networks to combat targeted therapy resistance

Drug resistance remains one of the greatest challenges facing precision oncology today. Despite the vast array of resistance mechanisms that cancer cells employ to subvert the effects of targeted therapy, a deep understanding of cancer signalling networks has led to the development of novel strategi...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrison, Peter T., Huang, Paul H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2018
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204552/
https://www.ncbi.nlm.nih.gov/pubmed/30072489
http://dx.doi.org/10.1042/EBC20180016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204552/
https://www.ncbi.nlm.nih.gov/pubmed/30072489
http://dx.doi.org/10.1042/EBC20180016

Ejemplares similares